303 related articles for article (PubMed ID: 34752803)
1. Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2.
Meister TL; Todt D; Brüggemann Y; Steinmann J; Banava S; Brill FHH; Steinmann J; Pfaender S; Steinmann E
J Hosp Infect; 2022 Feb; 120():9-13. PubMed ID: 34752803
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of
Idrees M; McGowan B; Fawzy A; Abuderman AA; Balasubramaniam R; Kujan O
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231450
[TBL] [Abstract][Full Text] [Related]
3. Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures.
Schütz D; Conzelmann C; Fois G; Groß R; Weil T; Wettstein L; Stenger S; Zelikin A; Hoffmann TK; Frick M; Müller JA; Münch J
Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L750-L756. PubMed ID: 33561380
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Povidone-Iodine Nasal Spray on Nasopharyngeal SARS-CoV-2 Viral Load: A Randomized Control Trial.
Zarabanda D; Vukkadala N; Phillips KM; Qian ZJ; Mfuh KO; Hatter MJ; Lee IT; Rao VK; Hwang PH; Domb G; Patel ZM; Pinsky BA; Nayak JV
Laryngoscope; 2022 Nov; 132(11):2089-2095. PubMed ID: 34724213
[TBL] [Abstract][Full Text] [Related]
6. Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control.
Hoseini-Tavassol Z; Ejtahed HS; Soroush AR; Sajjadpour Z; Hasani-Ranjbar S; Larijani B
Infect Disord Drug Targets; 2021; 21(8):e160921191568. PubMed ID: 33602078
[TBL] [Abstract][Full Text] [Related]
7. Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial.
Guenezan J; Garcia M; Strasters D; Jousselin C; Lévêque N; Frasca D; Mimoz O
JAMA Otolaryngol Head Neck Surg; 2021 Apr; 147(4):400-401. PubMed ID: 33538761
[TBL] [Abstract][Full Text] [Related]
8. Hydroxypropyl Methylcellulose-Based Nasal Sprays Effectively Inhibit In Vitro SARS-CoV-2 Infection and Spread.
Bentley K; Stanton RJ
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960612
[TBL] [Abstract][Full Text] [Related]
9. Effect of phthalocyanine oral and nasal antiseptic solutions on the infectivity of SARS-CoV-2 in patients with COVID-19: a randomized controlled trial.
Colado Simão AN; Perugini Stadtlober N; Stinghen Garcia Lonni AA; Venâncio LM; Lerner Trigo G; de Souza Cassela PLC; Mastellini Sanches Silva T; De Fátima Oliveira Hirth Ruiz M; Batisti Lozovoy MA; Tano ZN; da Fonseca Orcina B; Vieira Vilhena F; da Silva Santos PS
Ger Med Sci; 2023; 21():Doc07. PubMed ID: 37426884
[TBL] [Abstract][Full Text] [Related]
10. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
[TBL] [Abstract][Full Text] [Related]
11. Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
Meister TL; Brüggemann Y; Todt D; Conzelmann C; Müller JA; Groß R; Münch J; Krawczyk A; Steinmann J; Steinmann J; Pfaender S; Steinmann E
J Infect Dis; 2020 Sep; 222(8):1289-1292. PubMed ID: 32726430
[TBL] [Abstract][Full Text] [Related]
12. Potential mouth rinses and nasal sprays that reduce SARS-CoV-2 viral load: What we know so far?
de Toledo Telles-Araujo G; Caminha RDG; Kallás MS; Sipahi AM; da Silva Santos PS
Clinics (Sao Paulo); 2020 Nov; 75():e2328. PubMed ID: 33263622
[No Abstract] [Full Text] [Related]
13. Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection?
Casale M; Rinaldi V; Sabatino L; Moffa A; Ciccozzi M
Int J Immunopathol Pharmacol; 2020; 34():2058738420941757. PubMed ID: 32799596
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Virucidal Effect of Intranasally Delivered Chlorpheniramine Maleate Compound Against Severe Acute Respiratory Syndrome Coronavirus 2.
Westover JB; Ferrer G; Vazquez H; Bethencourt-Mirabal A; Go CC
Cureus; 2020 Sep; 12(9):e10501. PubMed ID: 32963923
[TBL] [Abstract][Full Text] [Related]
15. Effective
Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2.
Guareschi F; Del Favero E; Ricci C; Cantù L; Brandolini M; Sambri V; Nicoli S; Pescina S; D'Angelo D; Rossi I; Buttini F; Bettini R; Sonvico F
Eur J Pharm Sci; 2024 Feb; 193():106673. PubMed ID: 38103657
[TBL] [Abstract][Full Text] [Related]
17. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease.
Anderson DE; Sivalingam V; Kang AEZ; Ananthanarayanan A; Arumugam H; Jenkins TM; Hadjiat Y; Eggers M
Infect Dis Ther; 2020 Sep; 9(3):669-675. PubMed ID: 32643111
[TBL] [Abstract][Full Text] [Related]
18. Delivery of Agarose-aided Sprays to the Posterior Nose for Mucosa Immunization and Short-term Protection against Infectious Respiratory Diseases.
Seifelnasr A; Talaat M; Si XA; Xi J
Curr Pharm Biotechnol; 2024; 25(6):787-798. PubMed ID: 37533243
[TBL] [Abstract][Full Text] [Related]
19. Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2.
Moakes RJA; Davies SP; Stamataki Z; Grover LM
Adv Mater; 2021 Jul; 33(26):e2008304. PubMed ID: 34060150
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection.
Winchester S; John S; Jabbar K; John I
J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 33992687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
